GlassScriptPhysician profile
Imran Nisar Shaikh
NPI 1194891796
$1,016.14
in general payments reported to CMS, 2019-2025
18 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $41.12 · 2021: $61.73 · 2022: $14.40 · 2023: $116 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $147.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $118.88 | 2019 | |
| Travere Therapeutics, INC. | $104.43 | 2019 | |
| Philips North America LLC | $90.00 | 2019 | |
| Allergan, INC. | $80.40 | 2019-2020 | |
| Lilly USA, LLC | $72.05 | 2022-2025 | Jardiance |
| Axsome Therapeutics, INC. | $64.03 | 2025 | Sunosi, Auvelity |
| Harmony Biosciences LLC | $59.15 | 2023 | Wakix |
| Inspire Medical Systems, INC. | $56.23 | 2023-2025 | Inspire |
| Ceribell, INC. | $35.21 | 2025 | Pocket Eeg Device |
| Merck Sharp & Dohme LLC | $32.71 | 2019 | |
| Phathom Pharmaceuticals, INC. | $30.60 | 2025 | Voquezna |
| Chiesi USA, INC. | $29.09 | 2021 | |
| Scpharmaceuticals INC. | $25.91 | 2025 | |
| Idorsia Pharmaceuticals US INC | $18.96 | 2023 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $18.67 | 2019 | |
| Glaxosmithkline, LLC. | $17.77 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.